Monster Beverage Corp (MNST) concluded trading on Tuesday at a closing price of $52.51, with 2.03 million shares of worth about $106.45 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.06% during that period and on December 24, 2024 the price saw a gain of about 1.25%. Currently the company’s common shares owned by public are about 972.45M shares, out of which, 690.90M shares are available for trading.
Stock saw a price change of -0.87% in past 5 days and over the past one month there was a price change of -4.74%. Year-to-date (YTD), MNST shares are showing a performance of -10.61% which decreased to -8.05% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $43.32 but also hit the highest price of $61.22 during that period. The average intraday trading volume for Monster Beverage Corp shares is 5.61 million. The stock is currently trading -0.84% below its 20-day simple moving average (SMA20), while that difference is down -1.85% for SMA50 and it goes to 0.30% higher than SMA200.
Monster Beverage Corp (NASDAQ: MNST) currently have 972.45M outstanding shares and institutions hold larger chunk of about 65.97% of that.
The stock has a current market capitalization of $51.71B and its 3Y-monthly beta is at 0.74. PE ratio of stock for trailing 12 months is 33.74, while it has posted earnings per share of $1.56 in the same period. Its PEG reads 3.30 and has Quick Ratio of 2.51 while making debt-to-equity ratio of 0.14. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MNST, volatility over the week remained 1.90% while standing at 1.91% over the month.
Stock’s fiscal year EPS is expected to rise by 6.44% while it is estimated to increase by 13.22% in next year. EPS is likely to shrink at an annualized rate of 10.22% for next 5-years, compared to annual growth of 11.87% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Exane BNP Paribas on December 19, 2024 offering an Underperform rating for the stock and assigned a target price range of between $46 and $45 to it. On November 12, 2024, Argus Reiterated their recommendations, while on November 11, 2024, TD Cowen Reiterated their ratings for the stock with a price target of $55. Stock get a Neutral rating from UBS on November 08, 2024.
